Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Prostate Cancer

Survival Disparity Analysis Yields Unexpected Findings in mCRPC

Susan Halabi, PhD, discusses the unexpected results of a survival disparity analysis of African-American and Caucasian patients with metastatic castration-resistant prostate cancer.
Read More >>

Expert Emphasizes Inclusivity in Prostate Cancer Trials

Rethinking the Prostate Cancer Paradigm in the Urology Community

ASCO Adds New Combos for Metastatic Noncastrate Prostate Cancer

Practice in South Texas Offers Vertically Integrated Cancer Care

Regulatory Decisions Propel Nonmetastatic CRPC Paradigm Forward

View More Stories >>

View Conference Coverage

2018 International Lung Cancer Congress

2018 Pan Pacific Lymphoma Conference

2nd Annual Live Medical Crossfire® : Hematologic Malignancies

State of the Science Summit on A Summer of Progress: Updates from ASCO 2018

2018 State of the Science Summit on Breast Cancer

Dr. Choyke on Differences Between PET Scans in Prostate Cancer

Dr. Hussain on Potential of Enzalutamide in Prostate Cancer

Dr. Samuelson on the Comorbidities that Affect Treatment Decisions in Prostate Cancer

Dr. Yu on the Future of Castration-Sensitive Prostate Cancer

Dr. Hussain on the Treatment of Nonmetastatic CRPC

Dr. Hashmi on Immunotherapy in Prostate Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Managing Advanced Prostate Cancer in the Future

Hereditary Prostate Cancer Testing in Practice

Improvements in Detecting and Treating Metastatic CRPC

OncLive houses thousands of videos that provide updates and information.
See more Videos

Developments in the NETs Treatment Landscape

Apalutamide: A Next-Gen Agent for Nonmetastatic CRPC

The Value of AR-Targeted Therapy in CRPC

Understanding Nonmetastatic CRPC: An Overview

Prostate Cancer: Advice for Oncologists on AR-V7 Testing

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Redefining Advanced Prostate Cancer with Novel Imaging

Raoul S. Concepcion, MD, FACS, moderates this discussion with Daniel George, MD; Alec Koo, MD; Phillip Koo, MD; and Neal Shore, MD, FACS. The group of urologists and oncologists specializing in prostate cancer discusses redefining advanced prostate cancer with novel imaging.
View Now

Metastatic Prostate Cancer Update

Charles Ryan, MD, describes his approach to use of androgen receptor-targeted therapy for the treatment of castration-resistant prostate cancer. Dr. Ryan provides additional perspective on the topic of predictive markers.
View Now

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approval in CTCL, Breakthrough Therapy Designation in CRC, and More